A 16-year-old adolescent boy with a history of severe hemophilia A is undergoing an elective inguinal hernia repair. Which of the following is the best option for preventing or treating a bleeding complication in the setting of this disease?
First, I need to recall what hemophilia A is. It's a deficiency in clotting factor VIII, which is part of the intrinsic pathway. So, patients have prolonged PTT and normal PT. The main treatment for hemophilia A is replacement therapy with factor VIII concentrates.
Now, the scenario is elective surgery, specifically an inguinal hernia repair. The goal here is to prevent bleeding during and after surgery. The options aren't listed, but common treatments for hemophilia include factor VIII concentrates, desmopressin (DDAVP), antifibrinolytics like tranexamic acid, and maybe others.
DDAVP is used in mild hemophilia A as it releases von Willebrand factor and factor VIII from storage. But in severe cases, like this patient, DDAVP isn't effective because there's not enough factor VIII to release. So the mainstay would be factor VIII replacement.
Antifibrinolytics help by preventing the breakdown of clots but don't address the underlying deficiency. They're usually adjuncts. So the best option would be administering factor VIII concentrates to raise levels preoperatively and maintain them during and after surgery.
Wait, the options might include factor VIII, factor IX (for hemophilia B), DDAVP, or antifibrinolytics. Since the correct answer is likely factor VIII, the options that are incorrect would be the others. Let me make sure.
Hemophilia A is factor VIII deficiency, so the treatment is factor VIII replacement. Hemophilia B is IX deficiency. DDAVP is for mild A. Antifibrinolytics are adjuncts. So the correct answer is factor VIII concentrate. The distractors would be B, DDAVP, or antifibrinolytics.
Clinical pearl: Remember that DDAVP is only for mild hemophilia A. For severe cases or surgery, factor VIII replacement is essential. Also, factor IX is for hemophilia B, which is different. So the correct answer is the factor VIII option.
**Core Concept**
Hemophilia A is an X-linked recessive bleeding disorder caused by deficiency of clotting factor VIII. Treatment involves replacement therapy with factor VIII concentrates to correct the coagulation defect, especially in surgical settings where bleeding risk is high.
**Why the Correct Answer is Right**
Factor VIII replacement therapy directly addresses the underlying deficiency in hemophilia A by restoring the intrinsic coagulation pathway. In elective surgery, preoperative, intraoperative, and postoperative administration of factor VIII is critical to achieve hemostasis. This approach raises factor VIII levels to 80–100% of normal, preventing surgical bleeding and postoperative hematoma formation. It is the mainstay of treatment for severe hemophilia A, unlike adjunctive agents that do not replace the missing factor.
**Why Each Wrong Option is Incorrect**
**Option A:** Desmopressin (DDAVP) is effective in mild hemophilia A by releasing endogenous factor VIII but fails in severe cases due to depleted stores.
**Option C:** Antifibrinolytics like tranexamic acid prevent clot breakdown but do not correct the factor VIII